Harrow Health, Inc.
Harrow Health, Inc. (HROW) Revenue
Annual & quarterly revenue history · segment & region breakdown
HROW · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsHarrow Health, Inc. trailing twelve-month (TTM) revenue is $0.27B, an increase of 36.41% year-over-year from $0.27B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.27B | +$0.07B | +36.41% |
| 2024-12-31 | $0.20B | +$0.07B | +53.32% |
| 2023-12-31 | $0.13B | +$0.04B | +46.95% |
| 2022-12-31 | $0.09B | +$0.02B | +22.24% |
| 2021-12-31 | $0.07B | +$0.02B | +48.30% |
| 2020-12-31 | $0.05B | -$0.00B | -4.48% |
| 2019-12-31 | $0.05B | +$0.01B | +23.67% |
| 2018-12-31 | $0.04B | +$0.01B | +54.52% |
| 2017-12-31 | $0.03B | +$0.01B | +34.26% |
| 2016-12-31 | $0.02B | +$0.01B | +105.25% |
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare HROW revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Harrow Health, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Harrow Health, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Harrow Health, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HROW revenue · 4 questionsHROW's trailing twelve-month (TTM) revenue is $0.27B. That is an increase of 36.41% year-over-year from $0.27B in FY2025.
▸ Source: FMP · Harrow Health, Inc. SEC filings · GAAP · Harrow Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026